Company Search:
Advanced Search
Sponsored Links
Regeneus Ltd Company Snapshot
Regeneus Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other companies in this sector in Australia: Medibio Ltd (2016 sales of 1.81 million Australian Dollars [US$1.37 million] ), Paradigm Biopharmaceuticals Ltd (1.39 million Australian Dollars [US$1.06 million] ), and Imugene Limited (1.56 million Australian Dollars [US$1.19 million] ).

Sales Analysis. Regeneus Ltd reported sales of A$1.88 million (US$1.43 million) for the fiscal year ending June of 2016. This represents a decrease of 8.9% versus 2015, when the company's sales were A$2.06 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regeneus Ltd
  Stock Performance Chart for Regeneus Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .16
(Figures in Australian Dollars)
1 Week 3.3%   13 Weeks 3.3%  
4 Weeks 10.7%   52 Weeks 34.8%  
Regeneus Ltd Key Data:
  Ticker: RGS Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,877,759
(Year Ending Jan 2017).
Employees: N/A
  Currency: Australian Dollars Market Cap: 32,377,197
  Fiscal Yr Ends: June Shares Outstanding: 208,885,143
  Share Type: Ordinary Closely Held Shares: 79,628,198
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.